Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P33
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 4.52% |
| 2024 | 0.27% |
| 2023 | 15.63% |
| 2022 | -16.82% |
| 2021 | 6.44% |
| 2020 | -3.70% |
| 2019 | 7.47% |
| 2018 | 71.29% |
| 2017 | 48.74% |
| 2016 | 33.92% |